期刊文献+

摩氏摩根菌耐药性和超广谱β-内酰胺酶检测 被引量:6

Antibiotic resistance and detection of extended spectrum β-lactamases in Morganella morganii strains
原文传递
导出
摘要 目的了解摩根摩根菌临床分离株对抗菌药物的体外敏感性和临床分布,研究摩氏摩根菌超广谱β-内酰胺酶基因类型分布。方法用K-B法对67株摩氏摩根菌进行药物敏感性检测;PCR法检测超广谱β-内酰胺酶基因,并对PCR结果进行测序分析。结果摩氏摩根菌株对氨苄西林、头孢唑林、头孢呋辛、氨苄西林/舒巴坦、庆大霉素、呋喃妥因均已产生较高的耐药率;而对环丙沙星、左旋氧氟沙星和第三代头孢菌素的耐药率保持在较低水平;对亚胺培南、美洛培南、头孢西丁100%敏感。基因型分析显示有5株携带CTX-M基因,其中3株摩根摩根菌基因型为CTX-M-14型,2株为CTX-M-15型。结论摩氏摩根菌ESBLs检出率仍较低;5株产超广谱β-内酰胺酶摩氏摩根菌对多种抗菌药物耐药,其基因型为CTX-M-15或者CTX-M-14;需加强对不常见肠杆菌科细菌的耐药监测。 Objective To determine the antibiotic resistance and clinical distribution of Morganella morgani strains isolated from clinical specimens and explore the distribution and genetypes of the pathogen' s extended spectrum β-1actamases. Methods A total of 69 strains of Morganella morgani were analysed for their antimicrobial susceptibility. The blagene of ES- BLs producing isolates were detected by PCR and then sequenced. Results None of these Morganella morgani isolates was found resistant to imipenem, mempenem, and cefoxitin. The resistances of Morganella morgani isolates to common antibiotics were higher, but remained lower to fluoroquinolones and the third generation cephalosporins with a resistance range from 4% to 15%. Of the 69 isolates, 5 (7.46%) strains were identified as ESBLs producers. The genotypes of these strains included CTX-M-14 (2/5) and CTX-M-15 (3/5). Conclusion 5 Morganella morganii strains produce CTX-M-14 or CTX-M-15 ES- BLs, which results in their resistance to most β-lactams. More attention should be paid to the monitoring of resistance of these strains.
出处 《中国微生态学杂志》 CAS CSCD 2012年第8期744-745,749,共3页 Chinese Journal of Microecology
关键词 摩氏摩根菌 超广谱Β-内酰胺酶 耐药性 基因型 Morganella morgani Extended spectrum β-1 actamases Resistance Genetype
  • 相关文献

参考文献7

二级参考文献54

  • 1欧阳范献,卜平凤,陈允凤,黄瑾.铜绿假单胞菌ESBLs检测及其流行病学分析[J].中国热带医学,2004,4(4):519-521. 被引量:6
  • 2季淑娟,顾怡明,谭文涛,王丹丹,冯羡菊,周志慧,俞云松,陈亚岗,李兰娟.中国部分地区大肠埃希菌和肺炎克雷伯菌超广谱β内酰胺酶基因型研究[J].中华检验医学杂志,2004,27(9):590-593. 被引量:172
  • 3程玉林,陈民钧.吉戈菲肠杆菌中SHV-2耐药基因的序列分析[J].微生物学报,1994,34(3):226-230. 被引量:3
  • 4陈民钧,俞云松,王辉,徐英春.改进药敏折点标准 指导临床合理选择抗菌药物[J].中华检验医学杂志,2005,28(6):565-568. 被引量:17
  • 5Goossens H.MYSTIC program:summary of European data from 1997 to 2000.Diagn Microbiol Infect Dis,2001,41:183-189.
  • 6Yu YS,Zhou WL,Chen YG,et al.Epidemiological and antibiotic resistant study on extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Zhejiang Province.Chin Med J,2002,115:1479-1482.
  • 7Paterson DL,Mulazimoglu L,Casellas JM,et al.Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum β-lactamase production in Klebsiella pneumoniae isolates causing bacteremia.Clin Infect Dis,2000,30:473-478.
  • 8Yu WL,Jones RN,Hollis RJ,et al.Molecular epidemiology of extended-spectrum β-lactamase producing,fluoroquinolone-resistant isolates of Klebsiella pneumoniae in Taiwan.J Clin Microbiol,2002,40:4666-4669.
  • 9Bedenic B,Beader N,Zagar Z.Effect of inoculum size on the antibacterial activity of cefpirome and cefepime against Klebsiella pneumoniae strains producing SHV extended spectrum beta-lactamases.Clin Microbiol Infect,2001,7:626-635.
  • 10Medeiros AA.Evolution and dissemination of β-lactamases accelerated by generations of β-lactam antibiotics.Clin Infect Dis,1997,24:S19-S45.

共引文献207

同被引文献37

引证文献6

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部